Xilio Therapeutics Inc XLO インサイダー取引

Xilio Therapeutics Inc (XLO) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-03-26	Dr. James S. ShannonIndependent Director	5.00k	43.95k	買い	8.79	10.00k	100.00%
2026-02-13	Gilead Sciences, Inc.法人	3.74M	0.00	Open Market Derivative Acquisition	0.00	40.38M	10.20%
2026-01-01	Dr. Rene RussoPresident, CEO & Director	3.16k	0.00	Derivative Exercise and Retained Stock	-	23.24k	15.74%
2026-01-01	Mr. Kevin M. BrennanSVP of Finance & Accounting	226.71	0.00	Derivative Exercise and Retained Stock	-	455.00	99.31%
2026-01-01	Mr. Kevin M. BrennanSVP of Finance & Accounting	-130.43	1.17k	Derivative Exercise and Sale	9.00	455.00	-
2026-01-01	Mr. Christopher FrankenfieldCFO & COO	881.79	0.00	Derivative Exercise and Retained Stock	-	1.77k	99.39%
2026-01-01	Mr. Christopher FrankenfieldCFO & COO	-502.14	4.52k	Derivative Exercise and Sale	9.00	1.77k	-
2026-01-01	Dr. Katarina LuptakovaChief Medical Officer	1.19k	0.00	Derivative Exercise and Retained Stock	-	2.38k	100.00%
2025-11-21	Mr. Christopher FrankenfieldCFO & COO	-11.08k	0.00	Other Derivative Disposition	21.00	11.08k	-50.00%
2025-06-16	Dr. Rene RussoPresident, CEO & Director	2.59k	24.68k	買い	9.52	20.08k	14.82%
2025-06-16	Dr. James S. ShannonIndependent Director	5.00k	48.08k	買い	9.60 - 9.64	5.00k	-
2025-06-05	Gilead Sciences, Inc.法人	952.50k	0.00	Open Market Derivative Acquisition	10.50	952.50k	-
2025-06-05	Gilead Sciences, Inc.法人	952.50k	0.00	Open Market Derivative Acquisition	10.50	952.50k	-
2025-06-05	Gilead Sciences, Inc.法人	952.50k	0.00	Open Market Derivative Acquisition	10.50	952.50k	-
2025-06-05	Gilead Sciences, Inc.法人	13.34M	0.00	Open Market Derivative Acquisition	0.00	23.31M	133.68%